Benign Prostatic Hyperplasia (BPH) is a condition in which the prostate gland enlarges abnormally with age. While a normal prostate weighs approximately 20g, an enlarged prostate can exceed 100g and in extreme cases grow to 200g or more. This compressed tissue causes voiding disorders including a weak stream, residual urine sensation, frequent urination, and nocturia. If left untreated, it can lead to urinary tract infections, bladder dysfunction, and kidney damage.
According to Korean health statistics, the number of BPH patients in 2023 exceeded 1.53 million. The condition peaks in men aged 50 and above, with cases rising more in autumn and winter.
One of the most advanced surgical options is Holmium Laser Enucleation of the Prostate (HoLEP). Using a holmium laser, it precisely excises enlarged prostate tissue entirely through an endoscope—without any open incision—and can safely remove even 200g extra-large prostates. The laser simultaneously cuts and seals blood vessels, resulting in minimal blood loss and rapid recovery.
HoLEP is also effective for patients unresponsive to long-term medication. When residual urine exceeds 300mL or voiding difficulties persist, bladder dysfunction risk is high. Documented cases show patients recovering urine flow rates of 23.8mL/sec after HoLEP, with marked symptom improvement. Unlike TURP, HoLEP handles prostates of all sizes, with an incontinence rate under 1%, and is covered by health insurance.
Dr. Na Jun-chae of Goldman Urology (Jamsil branch) stated, "As BPH symptoms worsen, quality of life deteriorates significantly and the risk of complications increases. It is critical to receive the right treatment at the right time. If you are experiencing difficulty urinating, I encourage you to visit a urology clinic for an accurate diagnosis and appropriate treatment."